{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:14:29Z","timestamp":1761059669733},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CPB"],"published-print":{"date-parts":[[2014,1,31]]},"DOI":"10.2174\/1389201014666131226124348","type":"journal-article","created":{"date-parts":[[2014,2,6]],"date-time":"2014-02-06T15:38:34Z","timestamp":1391701114000},"page":"913-917","source":"Crossref","is-referenced-by-count":6,"title":["Vaccines against Clostridium perfringens Alpha-toxin"],"prefix":"10.2174","volume":"14","author":[{"given":"Masahiro","family":"Nagahama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/119191","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T08:42:28Z","timestamp":1448268148000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1389-2010&volume=14&issue=10&spage=913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,31]]},"references-count":0,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,1,31]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389201014666131226124348","relation":{},"ISSN":["1389-2010"],"issn-type":[{"value":"1389-2010","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1,31]]}}}